BUCKSCO.Today on MSN

A Planned GSK Expansion Pushes Company Beyond Montgomery County

GlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, announced a landmark investment ...
The Business Journals

GSK to build new factory in Upper Merion as part of $30B U.S. investment

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min GSK is the latest Big Pharma ...

GSK plc (NYSE:GSK) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript October 29, 2025 GSK plc beats earnings expectations. Reported EPS is $1.48, expectations ...
U.S. News & World Report

GSK Commits $30 Billion to US Research and Development, Factory Expansion, as Trump Visits UK

(Reuters) - Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure over five years, after U.S. President Donald Trump arrived in ...
The Impartial Reporter

GSK boosted by cancer and HIV drugs as Emma Walmsley bows out

Shares in the company rose on Wednesday morning as a result, lifting to their highest level for more than a year.
STAT

GSK CEO Walmsley to step down, be succeeded by company’s commercial lead

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — GSK on Monday said that Luke Miels, the company’s chief ...
Seeking Alpha

GSK: Compelling Value, No Red Flags Ahead Of Earnings, Blenrep FDA Decision Soon

GSK plc, aka GlaxoSmithKline, is rated a Buy at or below $45 due to relative undervaluation and a balanced, diversified portfolio. GSK's recent CEO transition and solid Q2 earnings have improved ...